Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

THE FUTURE OF FOOD: Disrupting protein production with microalgae

Descripción del proyecto

Comida sana para nuestro futuro

La seguridad alimentaria es una preocupación creciente, en especial cuando consideramos el rápido aumento de la población humana. Deben encontrarse alimentos nutritivos, abundantes y seguros para el ecosistema. Uno de los agentes con más éxito en este campo es la empresa emergente francesa Kyanos, que recibió el premio Most Novel Protein Process & IT en 2018. Gracias a su tecnología Cyclotrophy, pueden producir alimentos efectivos, seguros, libres de contaminantes y respetuosos con el medio ambiente. Basado en una proteína procesada de las microalgas AFA («Aphanizomenon flos-aquae»), su producto no necesita mucho espacio para crecer. Gracias al proyecto financiado con fondos europeos AFactory, los primeros productos estarán listos para su comercialización en dos años.

Objetivo

"By 2050, providing food for 10 billion people will become critical. Current protein sources cannot scale up without jeopardizing the environment.
French start-up Kyanos has developed a disruptive plant-based protein production technology with no environmental downside. Its unlimited supply potential is in line with the food industry requirements.
With unprecedented yields, cost effectiveness and health safety conditions, this industrial process, called ""Cyclotrophy"" caters for the growing market expectations for healthy, environmentally-friendly products.
Cyclotrophy won the Most Novel Protein Process & IT award at the Protein Summit 2018. It boosts the production of microorganisms such as microalgae and eliminates the unpredictability and the contaminants that affect traditional microalgae production. The process relies on smarter, more compact and more efficient production infrastructure and takes 20 times less space for a similar output. A fully functional lab-scale pilot is already running using AFA microalgae (Aphanizomenon flos-aquae). Thanks to a partnership with Altran Group, Kyanos is now about to ramp-up to the industrial scale.
The production capacity of the first factory is devised to quickly grow to reach 100 tonnes of AFA microalgae per year by 2023.
Kyanos will first target the high-margin dietary supplements market before addressing the massive food-ingredients demand. Drawing on existing distribution channels and health prescription dynamics, the initial product, AFA microalgae powder, will be sold to global health supplements companies. Kyanos will initiate EU distribution from year 2 onwards. In 2023, exports throughout Europe will represent 95% of the production, presumably gaining a 10% market share and inducing up to 110 indirect job creations in France and Europe
The objectives of the SMEi1 are: to secure full-scale design for the Cyclotrophy process scale-up; IP, FTO analysis and global market survey to schedule commercialization actions."

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Régimen de financiación

SME-1 - SME instrument phase 1

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) H2020-EIC-SMEInst-2018-2020

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

KYANOS BIOTECHNOLOGIES
Aportación neta de la UEn
€ 50 000,00
Dirección
23 AVENUE DE LOMBEZ APT 21 BATIMENT
31100 TOULOUSE
Francia
Pyme
Sí
Región
Occitanie Midi-Pyrénées Haute-Garonne
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 71 429,00